Biosimilar buy and bill sales in the Oncology and Immunology Space ( oncology/ hematology , rheumatology, gastroenterology, dermatology)* Diamond Club Recipient - FY 2024 Ranked 7th Nationally * Ranked #2 in National Sales for US market portfolio product launch

Current responsibilities include selling IV/SubQ biologic medications sold through BNB/Specialty pharmacies for rheumatological diseases.

Product lauch of a new class of medications (TPO Agonists - Thrombopoientin Receptor Agonist) for the treatment of thrombocytopenia in Chronic Liver Disease (CLD) patients undergoing procedures. Distribution through specialty pharmacies. - Call Points: Liver transplant centers, major teaching institutions, hepatologists, gastroenterologists, invasive radiologists, and hematologists - Northeast Field Advisory Board Member

Sr. Sales Specialist - UrologyEducated and consulted Urologist, Ob/Gyn and Internal Medicine physicians for over-active bladder medications, Vesicare and MyrbetriqRanked #1 in Summit Club for Washington D.C Region for 2017 and 2018 Ranked in top 30% FY2017Ranked in top 17.4% of sales force for FY 2018 YTD

Responsibilities include selling 4 medications to Gastroenterologists, Endocrinologists, and Internal Medicine physicians at The Johns Hopkins Hospital, The University of Maryland Medical Center, and surrounding regional hospitals and medical communities in the Greater Baltimore Area. Disease states covering Ulcerative Colitis, GERD, Type 2 Diabetes, and Hyperlipidemia.* Successfully launched Uceris for Ulcerative Colitis to Gastroenterologists in the Greater Baltimore area. Exceeded quoata - 123% of goal* Exceeded quotas for all four promoted products * Ranked in the top 10% to 15% for President's Cup throughout 2013 sales year* Ranked #1 in district for target bonus payout at 155% of incentive compensation plan

Established brand/company in the greater Baltimore market for a small start-up company with a focus on pain managment. Launched Sprix (Intranasal Ketorolac) for mild to moderate pain. Devised and instituted pain protocols for targeted customers: Neurologists, Orthopedic Surgeons, General Surgeons, Gynecologists, Urologists, Anesthesiologist/Pain Managment , and Emergency Medicine Health Care Professionals. Originated corporate sales strategy implemented nationwide. Designed strategic marketing sales pieces. Consistently ranked in the top tier for sales.* FY 2012 National Ranking 15/147 - Top 10%* FY 2011 National Ranking 28/157 - top 17%* Grew territory sales 221% in 2012 vs. 2011 ytd.

Created Pulmonary Arterial Hypertension (PAH) treatment networks for medical communities throughout Maryland for Cardiologists, Pulmonologists, Rheumatologists, and Infectious Disease Health Care Professionals. Generated sales exceeding corporate quotas for Ventavis and Tracleer (orphan status meds) Developed, maintained and utilized relationships with key opinion leaders at PAH Centers of Excellence in order to teach community health care professionals throughout sales territory proper diagnosis and treatment protocols for PAH. Established strong working relationships with Specialty Pharmacies to ensure patient product exposure.* 2010 Exceeded Q1/Q2 Tracleer and Ventavis goals: 155%/124% respectively * 2009 Tracleer shipment goal attainment 101%* 2009 Ventavis shipment goal attainment 105%* 2008 Tracleer enrollments increased 157% vs. 2007 enrollments

Promoted intravenous antibiotics: Maxipime/cefepime, Azactam/aztreonam, Prialt/ziconotide (Biologic for pain, BNB), and Abelcet/amphotericin B (antifungal) in Baltimore, MD and Wilmington, DE metro hospitals and outpatient centers. Targeted therapeutic areas and departments included: Infectious Disease, Surgery, Critical Care, Pulmonology, Oncology, Hospitalists, Cardiology and Emergency Medicine. Supported and developed numerous residency programs for above listed in-line products: The Johns Hopkins Hospital, University of Maryland Medical Center, and Christiana Hospital. Achieved formulary wins and therapeutic substitutions in all major medical centers and community hospitals throughout the state of Maryland. Achieved protocol and pathway implementation in all territory hospitals. Developed strong advocates and thought leaders for speaker programs* 2007 President’s Cup – 8th in nation Hospital Division Representatives* 2006 President’s Cup – 2nd out of 137 Hospital Division Representatives* 2004 Ranked 21 out of 190 Hospital Division representatives* 2003 President’s Cup –2nd in the nation for the High Hospital Territory Division* 2003 Brand Excellence Award – Azactam – Ranked 1st in nation* 2003 Award of Excellence – presented May 9, 2004

Promoted specialty pharmaceutical medications (IV and Oral) in both hospitals and office environments: Rocephin IV/IM, Versed IV, Romazicon, Toradol IM/IV, Ticlid, Coreg, and Posicor. - Specialties called on: Surgery, Anesthesiology, GI, Oncology, Infectious Disease, Cardiology, Rheumatology, Neurology, OB/GYN, Critical Care, Emergency Medicine, Pulmonology* Platinum Club Winner 1996/1998 ( Equivalent to Presidents Cup)* Special AchievementAward FY 1995/1997* Most Valuable Peer Award FY 1991/1992 * District Representative of the Year FY 1989/1990/1992* Government Achievement Award 1989

Promoted from Account Representative to Account Supervisor in first six months